CA2586946C - Nutrition containing fat blend - Google Patents

Nutrition containing fat blend Download PDF

Info

Publication number
CA2586946C
CA2586946C CA2586946A CA2586946A CA2586946C CA 2586946 C CA2586946 C CA 2586946C CA 2586946 A CA2586946 A CA 2586946A CA 2586946 A CA2586946 A CA 2586946A CA 2586946 C CA2586946 C CA 2586946C
Authority
CA
Canada
Prior art keywords
lipid
dha
dpan
total weight
epa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2586946A
Other languages
English (en)
French (fr)
Other versions
CA2586946A1 (en
Inventor
Bernd Stahl
Guenther Boehm
Christopher Beermann
Johan Garssen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nutricia NV
Original Assignee
Nutricia NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34927339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2586946(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia NV filed Critical Nutricia NV
Publication of CA2586946A1 publication Critical patent/CA2586946A1/en
Application granted granted Critical
Publication of CA2586946C publication Critical patent/CA2586946C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pediatric Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Dairy Products (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
CA2586946A 2004-11-11 2005-11-11 Nutrition containing fat blend Expired - Fee Related CA2586946C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04026825.2 2004-11-11
EP04026825A EP1656839A1 (en) 2004-11-11 2004-11-11 Nutrition containing lipid blend
PCT/EP2005/012122 WO2006050975A1 (en) 2004-11-11 2005-11-11 Nutrition containing fat blend

Publications (2)

Publication Number Publication Date
CA2586946A1 CA2586946A1 (en) 2006-05-18
CA2586946C true CA2586946C (en) 2014-09-30

Family

ID=34927339

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2586946A Expired - Fee Related CA2586946C (en) 2004-11-11 2005-11-11 Nutrition containing fat blend

Country Status (18)

Country Link
US (2) US8053471B2 (https=)
EP (3) EP1656839A1 (https=)
JP (1) JP2008519796A (https=)
CN (2) CN102511818B (https=)
AT (1) ATE457656T1 (https=)
AU (1) AU2005303903B2 (https=)
BR (1) BRPI0517479B1 (https=)
CA (1) CA2586946C (https=)
DE (1) DE602005019452D1 (https=)
DK (1) DK1809125T3 (https=)
ES (1) ES2341355T3 (https=)
NZ (1) NZ554629A (https=)
PL (1) PL1809125T3 (https=)
PT (1) PT1809125E (https=)
RU (1) RU2402927C2 (https=)
SG (1) SG143274A1 (https=)
UA (1) UA89207C2 (https=)
WO (1) WO2006050975A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
BRPI0613303A8 (pt) 2005-05-23 2018-01-30 Massachusetts Inst Technology composições que contêm pufa e/ou uridina e métodos de uso das mesmas
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
EP1962617A2 (en) * 2005-12-23 2008-09-03 N.V. Nutricia Infant nutritional compositions for preventing obesity
WO2008054193A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Nutritional products that comprise saccharide oligomers
MX2010000224A (es) 2007-06-26 2010-05-03 Nutricia Nv Mejoramiento de la memoria en individuos con mini-examen de estado mental de 24-26.
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002148A1 (en) * 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
CN100542411C (zh) * 2007-09-24 2009-09-23 张国浩 一种含ω-3多不饱和脂肪酸的营养均衡调和油及其生产方法
CN101951923B (zh) 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant
JP5335601B2 (ja) * 2009-07-30 2013-11-06 ビーンスターク・スノー株式会社 栄養組成物
WO2012087113A1 (en) * 2010-12-24 2012-06-28 N.V. Nutricia Improved nutritional tablet
TWI472300B (zh) 2011-12-27 2015-02-11 Abbott Lab 包含核苷酸及／或類胡蘿蔔素之低卡路里嬰兒配方於降低後續生命中不利健康效應之用途
WO2013192109A1 (en) 2012-06-17 2013-12-27 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
WO2014143272A1 (en) * 2013-03-13 2014-09-18 Matinas Biopharma Inc. Omega-3 pentaenoic acid compositions and methods of use
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
FR3045069B1 (fr) * 2015-12-14 2019-01-25 Metabolium Procede d'enrichissement de protistes en lipides riches en acides gras polyinsatures, plus particulierement de classe omega 3, et sa mise en oeuvre pour la production de ces lipides
CN109310662A (zh) * 2016-04-18 2019-02-05 N·V·努特里奇亚 用于减少生命早期应激诱导的认知下降/神经发生减少的亚油酸和α-亚麻酸
JP2020531589A (ja) * 2017-08-25 2020-11-05 ストラクト・ニュートリション・エルエルシー 頭部外傷後の神経損傷を予防、軽減、及び治療するための組成及び方法
WO2021092209A1 (en) * 2019-11-08 2021-05-14 Abbott Laboratories Bovine milk-isolated powdered exosomes, nutritional compositions and methods
WO2023232882A1 (en) 2022-05-31 2023-12-07 N.V. Nutricia Infant formula for improving cognitive development

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
KR940003473A (ko) * 1992-08-14 1994-03-12 이순목 n-3 지방산이 축적된 우유 및 우유용 사료조성물
NL9401644A (nl) * 1994-10-06 1996-05-01 Friesland Brands Bv Voedingsmiddel voor zwangere en lacterende vrouwen
US6582941B1 (en) * 1995-04-17 2003-06-24 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
US6432468B1 (en) * 1995-05-30 2002-08-13 Suntory Limited Domestic fowl eggs having a high content of highly unsaturated fatty acid, their production process and their use
DE69622722T2 (de) * 1996-11-20 2003-02-27 N.V. Nutricia, Zoetermeer Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms
JP2001516343A (ja) * 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
AU745551B2 (en) * 1997-03-27 2002-03-21 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
US6432684B1 (en) * 1997-04-11 2002-08-13 Abbott Laboratories Human desaturase gene and uses thereof
PT893064E (pt) * 1997-07-22 2003-04-30 Nestle Sa Composicao lipidica para formulacao infantil e processo de preparacao
WO2000020603A1 (en) * 1998-10-05 2000-04-13 Abbott Laboratories Altered fatty acid biosynthesis in insect cells using delta five desaturase
US6596302B2 (en) * 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
ITBO20000471A1 (it) 2000-07-31 2002-01-31 Vieri Ridolfi Dispositivo di supporto per prodotti da fumo particolarmente sigarette .
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
EP1392623A4 (en) * 2001-05-14 2005-05-04 Martek Biosciences Corp PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS
US20040209953A1 (en) * 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend

Also Published As

Publication number Publication date
RU2007121665A (ru) 2008-12-20
EP1809125B1 (en) 2010-02-17
PL1809125T3 (pl) 2010-07-30
BRPI0517479B1 (pt) 2015-06-09
PT1809125E (pt) 2010-05-20
CN102511818A (zh) 2012-06-27
CN101052316B (zh) 2012-02-22
DK1809125T3 (da) 2010-06-07
EP2191733A1 (en) 2010-06-02
CN102511818B (zh) 2014-12-24
US20080269330A1 (en) 2008-10-30
NZ554629A (en) 2010-09-30
SG143274A1 (en) 2008-06-27
EP1809125A1 (en) 2007-07-25
DE602005019452D1 (de) 2010-04-01
RU2402927C2 (ru) 2010-11-10
ES2341355T3 (es) 2010-06-18
US20120027885A1 (en) 2012-02-02
CN101052316A (zh) 2007-10-10
US8053471B2 (en) 2011-11-08
EP1656839A1 (en) 2006-05-17
ATE457656T1 (de) 2010-03-15
AU2005303903A1 (en) 2006-05-18
UA89207C2 (ru) 2010-01-11
JP2008519796A (ja) 2008-06-12
US8729123B2 (en) 2014-05-20
BRPI0517479A (pt) 2008-10-07
AU2005303903B2 (en) 2012-05-31
WO2006050975A1 (en) 2006-05-18
CA2586946A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
US8729123B2 (en) Nutrition containing fat blend
Lapillonne et al. Lipid needs of preterm infants: updated recommendations
Sanders Essential fatty acid requirements of vegetarians in pregnancy, lactation, and infancy
US20090054329A1 (en) Composition with docosapentaenoic acid
RU2558853C2 (ru) Эффекты метаболического импринтинга структурированных липидов
Lapillonne Enteral and parenteral lipid requirements of preterm infants
CA2729286C (en) Nutritional compositions containing punicalagins
Briend et al. Lipid intake in children under 3 years of age in France. A position paper by the Committee on Nutrition of the French Society of Paediatrics
Koletzko Trans Fatty Acids and the Human Infant¹
CN115104731B (zh) 营养组合物以及包含所述营养组合物的食品
Hendricks et al. Significance of milk fat in infant formulae
Mena et al. Fats
Scott Structured lipid: a functional ingredient to closely match infant formula to breast milk
Zhang et al. Health Effects of Docosahexanoic Acid (DHA)‒Enriched Eggs
Hamda et al. The Role of Dietary Docosahexaenoic Acid (DHA) for Cognitive Function
Hartmann et al. Longitudinal measures of visual acuity in full-term human infants fed different dietary fatty acids
Ghebremeskel et al. The role of essential fatty acids and antioxidants in neurovascular development and complications of prematurity
Freitas et al. DHAid™–The vegetarian source
Childs et al. Dietary Omega-3 Sources during Pregnancy and the Developing Brain: Lessons from Studies in Rats
CONNOR et al. Importance of Dietary Omega-3 Fatty Acids in Retinal Function

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20181113